Navigation Links
Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting
Date:10/31/2009

SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced the presentation of new data from fidaxomicin's North American phase 3 study at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia, PA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO)

Mark A. Miller, M.D., head of the Division of Infectious Diseases, Chair of the Infection Prevention and Control Unit at the Jewish General Hospital in Montreal, Quebec, Canada, presented results showing that fidaxomicin is associated with faster resolution of diarrhea. In patients with more pronounced diarrhea (ie. not resolving in the first 24 hours of therapy), fidaxomicin was associated with a faster time to resolution of diarrhea than vancomycin (79 hours vs. 105 hours, p=0.056). It is possible that decreasing the duration of diarrhea may have a direct impact on reducing the spread of CDI in healthcare facilities and lowering overall environmental spore contamination, thereby decreasing CDI rates and leading to earlier discharge of CDI patients from the hospital.

In another presentation, Kathleen M. Mullane, D.O., an investigator from the University of Chicago, Department of Medicine, Section of Infectious Diseases, in Illinois, presented data that indicated fidaxomicin may be a more effective therapy for CDI in patients requiring concomitant antibiotics. Treatment of CDI is often complicated by systemic infections requiring concomitant antibiotics. The analysis indicated that in patients receiving concomitant antibiotics, those treated with fidaxomicin versus vancomycin, had a significantly improved global cure rate
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
3. Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC
4. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
5. AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually
6. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
7. iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology
8. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
9. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
10. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
11. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... UK (PRWEB) May 29, 2015 ... Ltd. (Chem-Report ) signed a partnership agreement for ... now authorised to distribute and sell research reports ... Manager at Partners Department, commented upon the agreement: ... reports on key petroleum and chemical markets on ...
(Date:5/29/2015)... 2015  Caris Life Sciences ® , a ... of precision medicine, today announced the presentation of ... utility of Caris Molecular Intelligence ® , the ... to identify targeted treatment options for patients with ... studies, results of which are to be presented ...
(Date:5/29/2015)... 29, 2015 Seoul Semiconductor (CEO: ... LED technology, on May 28th announced that it ... by strengthening its high efficient and high reliable ... Since 2011 Seoul Semiconductor has developed efficient and ... and has supplied LEDs for headlamps to global ...
(Date:5/28/2015)... May 28, 2015  Quest Diagnostics Incorporated (NYSE: ... services, announced that it is scheduled to speak at ... Steve Rusckowski , the company,s President and CEO, ... strategy.  The presentation is scheduled for Tuesday, June 2, ... presentation will be webcast live during the conference and ...
Breaking Biology Technology:Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6Seoul Semiconductor Increases the Global Automotive LED Market Share with its High Efficient and Reliable LEDs for Automotive Lightings 2Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference 2
... & Myers, Inc.,(NYSE: RBN ) announced today that ... its Board of Directors, increasing the size from,seven to ... to,stand for election at the January 7, 2009 annual ... the board., Richard J. Giromini, 55, is President ...
... OMAHA, Neb., Oct. 29 Transgenomic, Inc. (OTC,Bulletin Board: ... 30, 2008. The Company,s financial results are presented in,the ... sales from continuing operations were $5.4 million during the ... comparable period of,2007. Gross profit from continuing operations was ...
... Ended September ... 30, 2008, ... the nine-month period ended,September 30, 2008. During this period, Genmab reported the ... the nine,month period ended September 30, 2008. In the same period of ...
Cached Biology Technology:Robbins & Myers, Inc. Elects New Board Members 2Transgenomic, Inc. Reports Third Quarter 2008 Results 2Transgenomic, Inc. Reports Third Quarter 2008 Results 3Transgenomic, Inc. Reports Third Quarter 2008 Results 4Transgenomic, Inc. Reports Third Quarter 2008 Results 5Transgenomic, Inc. Reports Third Quarter 2008 Results 6Transgenomic, Inc. Reports Third Quarter 2008 Results 7Genmab Announces Results for the First Nine Months of 2008 2Genmab Announces Results for the First Nine Months of 2008 3Genmab Announces Results for the First Nine Months of 2008 4Genmab Announces Results for the First Nine Months of 2008 5
(Date:5/28/2015)... ALLEN, Va. , May 28, 2015 /PRNewswire/ ... the release of a new report titled "Markets ... materials (reversible polymers, inorganic capsule and vascular systems, ... coatings) will grow to around $2.7 billion by ... deliverable from n-tech,s extensive coverage of smart materials. Other ...
(Date:5/26/2015)... 26, 2015 Research and ... of the "Saudi Arabia Biometric Systems Market ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems ... is projected to grow at over 22% CAGR ... attributed to the surging demand for better biometric ...
(Date:5/22/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... its promotional pricing and making the Wocket generally available for ... , Head of Marketing said, "We,ve extended the opportunity to ... of May. To get your wocket at this special price, ... store on June 1, you,ll receive a unique code that ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... U.S. Department of Energy,s (DOE) Argonne National Laboratory will ... processor-hours of computing time at Argonne,s Leadership Computing Facility ... Gene/P, a supercomputer capable of performing 557 trillion calculations ... research in weeks or months rather than years. ...
... N.J. , July 28 BIO-key International, Inc. ... solutions, today reported financial results for the second quarter and ... clarity and consistency, the data presented in this release relative ... of the company,s fingerprint-based Biometrics Division. The company completed the ...
... have developed a new version of a medication, first isolated ... in pill form to relieve the most severe forms of ... article on the topic appears in the current issue of ... C&EN Senior Editor Bethany Halford notes that a sea snails, ...
Cached Biology News:Supercomputers take science by storm 2Supercomputers take science by storm 3BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results 2BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results 3BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results 4BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results 5BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results 6BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results 7
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
...
Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
... ideal small concentrator for the molecular biology ... water and organic solvents from a variety ... and round bottom flasks. Making it an ... ,The built-in special runs for working with ...
Biology Products: